Floatz logo

CBL-0137 FREE BASE

Locally Advanced or Metastatic Melanoma

Fox Chase Cancer CenterSmall moleculeEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
23/ 100
Competitive Position
95/ 100

Competitive context

449 Active assets in the Locally Advanced or Metastatic Melanoma cohort.

Asset / SponsorPhaseRating
Gm-Csf
Ultimovacs ASA
Phase 4BBB
Sargramostim
Mayo Clinic
Phase 3BBB
Cediranib
M.D. Anderson Cancer Center
Phase 3BBB
Ifa
Craig L Slingluff, Jr
Phase 2BB
Tebentafusp
Immunocore Ltd
Phase 3BB

View all 50 →

Same molecule, other indications

CBL-0137 FREE BASE is also rated in:

Metastatic Malignant Neoplasm in the Central Nervous SystemDormant
CC
Indicative ·
44 / 100
View asset →
diffuse midline glioma, H3 K27-alteredDormant
CC
Indicative ·
44 / 100
View asset →
diffuse intrinsic pontine gliomaDormant
CC
Indicative ·
44 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →